The recovery strategies to support cervical cancer elimination in lower-and middle-income countries (LMICs) following COVID-19 disruptions
Open Access
- 29 June 2023
- journal article
- review article
- Published by Elsevier in Preventive Medicine Reports
- Vol. 35, 102291
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Human Papillomavirus Vaccination After COVID-19JNCI Cancer Spectrum, 2021
- 38 A training program to build capacity for cervical cancer prevention in MozambiqueInternational Journal of Gynecological Cancer, 2020
- Elimination of cervical cancer in low‐ and middle‐income countries: Inequality of access and fragile healthcare systemsInternational Journal of Gynecology & Obstetrics, 2020
- Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self-sampled HPV typingInfectious Agents and Cancer, 2020
- Strengthening global commitment to eliminating cervical cancer: What lessons from the past can we apply to the future?Journal of Global Health, 2020
- Affordable human papillomavirus screening needed to eradicate cervical cancer for allThe Lancet Global Health, 2019
- What is needed now for successful scale-up of screening?Papillomavirus Research, 2019
- HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancerAIDS, 2018
- The Doha declaration in action: An examination of patent law flexibilities in the South African acquired immunodeficiency syndrome epidemicJournal of Health Specialties, 2017
- Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in TanzaniaHealth Policy and Planning, 2016